Cyient Shares Drop 6% as Buyback Record Date Passes: What to Expect

Cyient shares witnessed a sharp 6% decline on Wednesday as the stock turned ex-record date for its highly anticipated ₹720 crore share buyback program. The price correction follows the conclusion of the eligibility window, impacting investors who were looking to participate in the tender offer.

Understanding the Ex-Record Date Impact

The recent volatility in Cyient’s stock price is a direct result of the company reaching its record date of June 17. For the ₹720 crore buyback, Cyient has offered to repurchase up to 64 lakh shares at a price of ₹1,125 per share. This price represents a significant premium of approximately 24% over the previous closing price.

Under SEBI’s T+1 settlement rule, only shareholders holding the stock in their demat accounts as of the record date are eligible to tender their shares. Investors who purchased shares on or after the record date will receive their holdings on the next trading day, making them ineligible for the buyback. This technical transition often leads to a price adjustment as the "buyback premium" is no longer available to new buyers.

The Mechanics of Cyient’s Buyback

This marks Cyient’s first share buyback since 2019. A buyback is a corporate action where a company uses surplus cash to repurchase its own shares from the market, typically at a premium to the prevailing market price. Such moves are generally intended to enhance shareholder value, optimize capital structure, or prevent hostile takeovers. While the entitlement ratio and final execution details are yet to be announced, the company has secured shareholder approval to proceed with the ₹1,125 per share offer.

Market Outlook and Brokerage Sentiment

Despite the buyback, Cyient faces significant headwinds in its long-term price performance. The stock has struggled throughout the year, down nearly 23% in 2024 (noted as 2026 in reports), and has seen a massive 36% decline over the last year. The company currently maintains a market capitalization of less than ₹9,540 crore.

Brokerage firms remain cautious regarding the stock's immediate trajectory. Emkay has maintained a 'Reduce' call on Cyient, although it slightly increased its target price from ₹850 to ₹900. This updated target implies a downside potential of less than 1% from the previous close of ₹907.65.

Медвежьи настроения обусловлены замедлением роста в 2026 финансовом году из-за макроэкономических трудностей. Хотя расходы на инженерные исследования и разработки (ER&D) остаются на стабильном уровне с ростом в пределах от середины до верхней границы однозначных чисел, сохраняются определенные операционные проблемы. В частности, период оборачиваемости запасов DLM увеличился на 63 дня, что было вызвано слабыми доходами, специфическими требованиями программ заказчиков и сложностями в глобальных цепочках поставок.

Основные выводы